A Study of LY2624587 in Patients With Advanced Cancer

Clinical trial NCT01139788 · COMPLETED

Trial details

NCT number: NCT01139788
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Metastatic Cancer

Start date: 2010-06-01
Primary completion: 2011-11-01
Enrollment: 56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.